| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | COLL Collegium Pharmaceutical, Inc | Tupper Colleen45 | EVP &Chief Financial Officer | Sell | 3,453 | $30.00 | $103,591.05 | -1.0% | +2.0% | +28.9% | |
| Mar 7, 2025 | COLL Collegium Pharmaceutical, Inc | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 5,643 | $30.00 | $169,299.49 | -1.9% | +2.0% | +28.9% | |
| Mar 6, 2025 | COLL Collegium Pharmaceutical, Inc | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 15,387 | $30.00 | $461,671.55 | -10.8% | -1.3% | +25.0% | |
| Mar 6, 2025 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 1,000 | $27.99 | $27,986.30 | -1.3% | -8.7% | -31.7% | |
| Mar 6, 2025 | INIS International Isotopes Inc | Bagerdjian Shahe | Pres. &CEO | Buy | 177,000 | $0.05 | $8,850.00 | +1.9% | - | - | |
| Mar 6, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Daly Jason B. | EVP, Chief Legal Officer | Sell | 90,000 | $8.80 | $792,159.60 | -44.5% | -17.7% | +51.1% | |
| Mar 6, 2025 | COLL Collegium Pharmaceutical, Inc | Kuhlmann Shirley R.49 | EVP And General Counsel | Sell | 86,067 | $28.19 | $2,426,633.99 | -17.8% | -1.3% | +25.0% | |
| Mar 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Boyer Andrew S | Executive Vice President | Sell | 125,000 | $8.89 | $1,111,250.00 | -30.1% | -16.9% | +47.9% | |
| Mar 5, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Daniell Richard | Exec. VP, European Commercial | Sell | 70,961 | $15.91 | $1,128,642.09 | -32.8% | +8.1% | +99.7% | |
| Mar 5, 2025 | ELAN Elanco Animal Health Inc | Hoover R David50 | Director | Buy | 25,000 | $10.90 | $272,557.50 | +13.5% | +24.1% | +120.5% | |
| Mar 5, 2025 | HIMS Hims & Hers Health, Inc. | Pendarvis Christiane | Director | Sell | 12,500 | $40.00 | $500,000.00 | -52.3% | +33.8% | -61.2% | |
| Mar 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Konidaris Tasos | Executive Vice President &CFO | Sell | 100,000 | $8.91 | $891,000.00 | -13.9% | -16.9% | +47.9% | |
| Mar 5, 2025 | LNTH Lantheus Holdings, Inc. | Blanchfield Paul54 | President | Sell | 2,084 | $98.00 | $204,232.00 | -2.2% | -22.7% | -24.1% | |
| Mar 5, 2025 | GTBIF Green Thumb Industries Inc. | Kravitz Bret | General Counsel And Secretary | Sell | 160,000 | $6.49 | $1,038,400.00 | -24.3% | - | - | |
| Mar 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Alva Emily Peterson | Director | Sell | 80,000 | $8.90 | $712,000.00 | -31.9% | -16.9% | +47.9% | |
| Mar 5, 2025 | ANIP Ani Pharmaceuticals Inc | Gutwerg Ori47 | SVP, Generics | Sell | 5,384 | $60.00 | $323,049.00 | -2.7% | +3.3% | +26.7% | |
| Mar 5, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Fox Christine | EVP, Head Of U.s. Commercial | Sell | 6,181 | $15.80 | $97,639.02 | -4.9% | +8.1% | +99.7% | |
| Mar 5, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Francis Richard D | President And CEO | Sell | 23,773 | $15.80 | $375,533.70 | -4.1% | +8.1% | +99.7% | |
| Mar 5, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Daniell Richard | Exec. VP, European Commercial | Sell | 140,372 | $15.80 | $2,217,406.52 | -36.7% | +8.1% | +99.7% | |
| Mar 5, 2025 | TEVA Teva Pharmaceutical Industries Ltd | McAvoy David R. | EVP, Chief Legal Officer | Sell | 4,827 | $15.80 | $76,250.43 | -15.9% | +8.1% | +99.7% | |
| Mar 5, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Hughes Eric A | See "remarks" | Sell | 23,251 | $15.80 | $367,287.74 | -74.2% | +8.1% | +99.7% | |
| Mar 5, 2025 | DERM Journey Medical Corp | Maraoui Claude | President &CEO | Sell | 70,556 | $5.11 | $360,761.67 | -1.1% | +37.7% | +50.1% | |
| Mar 4, 2025 | ETST Earth Science Tech, Inc. | Rose Christopher Alan | CTO | Buy | 31,500 | $0.16 | $4,935.00 | +26.7% | - | - | |
| Mar 4, 2025 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, EVP &Treasurer | Sell | 4,231 | $27.54 | $116,515.39 | -4.2% | -8.1% | -27.7% | |
| Mar 4, 2025 | ORGO Organogenesis Holdings Inc. | Driscoll Michael Joseph | Director | Sell | 25,000 | $5.10 | $127,535.00 | -13.0% | -47.2% | -43.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.